July 08, 2025

EVOO, Petrolatum Both Improve Skin Barrier Metrics

A clinical trial in healthy adults found that both extra virgin olive oil and petrolatum significantly improved skin hydration and barrier function, with differing effects on water loss and skin cell turnover.

Conexiant

July 08, 2025

Waist Size Plus BMI Predicts Mortality

A major long-term study of postmenopausal women found that waist circumference, when assessed alongside BMI, improved mortality risk prediction compared with BMI alone.

Conexiant

July 08, 2025

Mediterranean Diet’s 30-Year Legacy

A sweeping 30-year review confirms the Mediterranean-style diet lowers risks of heart disease, diabetes, cancer, and cognitive decline—while supporting global sustainability.

Conexiant

July 08, 2025

No Safe Level for Processed Foods

A meta-analysis finds no safe level of processed meat, sugary drinks, or industrial trans fats—each linked to increased chronic disease risk.

Conexiant

July 08, 2025

Orforglipron Lowers A1c, Weight in T2D Patients 

A 40-week trial presented at ADA's 85th Scientific Sessions showed that daily oral orforglipron significantly lowered blood sugar and body weight in adults with early type 2 diabetes.

Conexiant

July 08, 2025

Higher BMI, Heart Disease Raise Cancer Risk 

Obesity raises breast cancer risk more sharply in postmenopausal women with heart disease, per data from 168,000+ women in two major European cohorts.

Conexiant

July 08, 2025

Natural Cycle Beats HRT in FET Outcomes

A randomized trial found that using a natural cycle to prepare the endometrium for frozen embryo transfer in ovulatory women led to higher live birth rates and fewer complications compared to hormone replacement therapy.

Conexiant

July 08, 2025

New Obesity Framework Reclassifies 1 in 5 Adults

EASO’s expanded obesity definition incorporating waist-to-height ratio and comorbidities reclassifies 18.8% of overweight adults, but mortality benefits remain uncertain.

Conexiant

July 08, 2025

Does Deprescribing Do More Than Less?

Deprescribing interventions reduce the number of medications taken by older adults but show no clear effect on hospitalization, mortality, or quality of life—and appear to be safe.

Conexiant